Drug Profile

Econazole nitrate foam

Alternative Names: Ecoza

Latest Information Update: 04 Aug 2015

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Quinnova Pharmaceuticals
Developer Exeltis USA Dermatology
Class Antifungals; Azoles; Imidazoles; Small molecules
Mechanism of Action 14-alpha demethylase inhibitors

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

Highest Development Phases

Marketed Tinea pedis

Most Recent Events

15 Jul 2015 Exeltis USA Dermatology has patent protection 5 993 830 for econazole nitrate foam in USA before July 2015
04 Nov 2014 Everett Laboratories is now called Exeltis USA
31 Oct 2014 Quinnova Pharmaceuticals is now called Exeltis USA Dermatology

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com